Dicerna Pharmaceuticals

JPM23: After rock climbing in biotech, Novartis' CMO is back to support hopeful hike to US summit
Fierce Biotech
Thu, 01/12/23 - 10:36 am
Novartis
JPMHC 2023
Dicerna Pharmaceuticals
Axcella Health
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Fierce Biotech
Thu, 11/18/21 - 10:54 am
Novo Nordisk
M&A
Dicerna Pharmaceuticals
RNAi
Dicerna guides Roche-partnered hepatitis B drug past early test
Fierce Biotech
Thu, 08/6/20 - 10:15 am
Roche
Dicerna Pharmaceuticals
hepatitis B
RG6346
clinical trials
After big year, RNAi drugmakers compete to prove what comes next
BioPharma Dive
Sat, 01/18/20 - 07:37 pm
RNAi
JPMHC 2020
Alynylam
Arrowhead Pharmaceuticals
Dicerna Pharmaceuticals
Roche pays $200M for rights to Dicerna's hepatitis B RNAi drug
Fierce Biotech
Thu, 10/31/19 - 10:29 am
Roche
Dicerna Pharmaceuticals
RNAi
hepatitis B
DCR-HBVS
Dicerna gets breakthrough therapy designation for DCR-PHXC to treat primary hyperoxaluria type 1
Pharmaceutical Business Review
Tue, 07/16/19 - 11:04 pm
Dicerna Pharmaceuticals
FDA
breakthrough therapy
Primary Hyperoxaluria
RNAi company Dicerna raises $100M follow-on
BioCentury
Fri, 09/7/18 - 05:47 pm
Dicerna Pharmaceuticals
RNAi
Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Yahoo/BusinessWire
Sat, 04/19/14 - 10:04 am
Dicerna Pharmaceuticals
Biotech IPOs: Class of 2014 still rolling as investors line up to cash in
Fierce Biotech
Fri, 02/14/14 - 01:09 pm
biotech
IPOs
Dicerna Pharmaceuticals
Ultragenyx
Auspex
GlycoMimetics
Revance Therapeutics
Two biotech IPOs blast off, spurring dreams--and fears--of an attempted gold rush
Fierce Biotech
Fri, 01/31/14 - 09:11 am
IPOs
biotech
Dicerna Pharmaceuticals
Ultragenyx
Dicerna Pharma IPO: Existing Stockholders Want To Buy Majority Of Deal
Seeking Alpha
Mon, 01/27/14 - 11:57 am
Dicerna Pharmaceuticals
IPOs
Merck
Novartis
RNAi Developer Dicerna Pharmaceuticals to IPO
Nanalyze
Sun, 01/5/14 - 12:34 pm
RNAi
Dicerna Pharmaceuticals
IPO